Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EXTI - only public co. developing liver device -- Ignore unavailable to you. Want to Upgrade?

To: MaxLeverage who wrote (234)	3/9/1998 4:55:00 AM
From: Shawn Donahue	Read Replies (1) \| Respond to of 1063

Here is another reason for the need of EXTI to quickly develop their proprietary liver dialysis machine! Maybe instead of the Government turning this crisis into a reason for an expanded educational campaign...someone at EXTI or a stockholder with connections can contact Surgeon General David Satcher for the government to help fund EXTI in speeding up development of their liver treatment, instead of just making the public aware of the problem..let's help solve it with a viable treatment! GOV'T TO WARN HEPATITUS C VICTIMS By LAURA MECKLER .c The Associated Press WASHINGTON (AP) - Some 1 million Americans are infected with incurable hepatitis C and do not know it, Surgeon General David Satcher said while outlining plans to inform the public. The effort will focus on an estimated 300,000 people who received tainted blood in blood transfusions before a re- liable test was developed in mid-1992. It also will include a general public education campaign. ''Hepatitis C is a grave threat to our society,'' Satcher told a House subcommittee Thursday. ''We know that many Americans infected ... are unaware they have the disease.'' The Department of Health and Human Services' campaign will encourage people to get tested for the serious liver infection, which was not identified until 1988. It can take 20 years for symptoms to surface. There is NO CURE, but various treatments are in use and doctors are SEARCHING for improved therapies. Worldwide, an estimated 170 MILLION PEOPLE are infected. U.S. health officials estimate 4 MILLION AMERICANS have hepatitis C and a quarter of them are unaware of it. ''These people need to be told,'' said Rep. Christopher Shays, R-Conn., chairman of the House Government and Oversight's human resources subcommittee. ''They need to be tested. Many will need treatment, and many will need to learn how to prevent further spread of the disease.'' He compared the government's inertia on hepatitis C to its early reaction to AIDS. ''Federal public health agencies have often pondered, but never implemented, a comprehensive response to this insidious infectious agent,'' he said. New research suggests hepatitis C patients are particularly vulnerable to LIVER FAILURE, and the virus is the leading reason for LIVER TRANSPLANTS in the United States. Intravenous drug users make up the vast majority of hepatitis C victims. But about 300,000 people may have contracted it from a blood transfusion before the first screening tests were created in 1990. Thanks to improved screenings, the risk of infection through a blood transfusion today is very small. Satcher said the department plans to write to people who received blood before 1992 from donors who later tested positive for the virus. These blood recipients have a 40 percent to 70 percent chance of having the virus. It may be several months before the letters are sent, though. HHS agencies must still recommend details to Secretary Donna Shalala, who then will issue a regulation guiding the program. Blood banks nationwide then must identify potential victims. They will have to check their records for any donor who tested positive for hepatitis C since 1992, then check if he or she donated blood before. If so, they will have to trace the earlier donation to the recipient. But this will not find those who received tainted blood from a donor who never donated again. It will not reveal those infected by dirty needles or sexual contact. To reach them, Satcher said, the government plans an educational campaign for health care providers and the general public, an effort first recommended last summer by a Public Health Service blood advisory committee. Details will be announced in about a month, Satcher said. While the number of new infections has dropped dramatically over the last several years, 30,000 NEW CASES appear EACH YEAR, and about 10,000 people die annually.

To: MaxLeverage who wrote (234)	3/9/1998 11:43:00 AM
From: Danny Kim	Read Replies (1) \| Respond to of 1063

Richard, I plan to frame all forward looking posts if EXTI does indeed take off. I recently read an article in the LA-Times (Friday or thursday), on their website, about USC and UCLA slated to receive approx $100M each! for biotech research from a person who owns several biotech companies in LA. One of his companies are doing research on artifical pancreas. Apparently there are many trade/investment organizations located in LA for biotech/artifical organ developmen. The article mentions some consortium of biotech companies locted in souther cal. I will try to locate the article and send it to EXTI. It seems to me partnering with one of these companies may get SYBIOL off the ground...though may not be the best financing option for EXTI but it would be better than no financing. ANythoughts out there?